Ian Taylor - 16 Aug 2021 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role: Chief Scientific Officer
Signature: /s/ Matthew Batters, as attorney-in-fact for Ian Taylor
Issuer symbol: ARVN
Transactions as of: 16 Aug 2021
Net transactions value: -$1,425,917
Form type: 4
Filing time: 18 Aug 2021, 21:05:09 UTC
Next filing: 17 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARVN	Common Stock	Options Exercise	$320,000	+20,000	+25%	$16.00	98,645	16 Aug 2021	Direct
transaction	ARVN	Common Stock	Sale	$802,141	-9,237	-9.4%	$86.84	89,408	16 Aug 2021	Direct	F1, F2
transaction	ARVN	Common Stock	Sale	$917,204	-10,462	-12%	$87.67	78,946	16 Aug 2021	Direct	F1, F3
transaction	ARVN	Common Stock	Sale	$26,572	-301	-0.38%	$88.28	78,645	16 Aug 2021	Direct	F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARVN	Stock Option (right to buy)	Options Exercise	$0	-13,804	-48%	$0.000000	14,797	16 Aug 2021	Common Stock	13,804	$16.00	Direct	F5
transaction	ARVN	Stock Option (right to buy)	Options Exercise	$0	-6,196	-23%	$0.000000	21,149	16 Aug 2021	Common Stock	6,196	$16.00	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2021
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.23 to $87.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.23 to $88.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.26 to $88.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5	This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022.
F6	This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.